Sep 03
MOSQUITO SPRAYING SET FOR DELAWARE COUNTY TO CONTROL WEST NILE VIRUS THREAT
Uncategorized
Add comments
NORRISTOWN - Weather permitting, the state Department of Environmental Protection and West Nile staff in Delaware County will apply treatments the evening of Thursday, Sept. 4 in Concord Township to control adult mosquito populations.
Complete news release available at http://www.ahs.dep.state.pa.us/newsreleases/default.asp?ID=5273
MOSQUITO SPRAYING SET FOR MORGAN, FRANKLIN TOWNSHIPS IN GREENE COUNTY TO CONTROL WEST NILE VIRUS THREAT
MOSQUITO SPRAYING SET FOR DELAWARE COUNTY TO CONTROL WEST NILE VIRUS THREAT
MOSQUITO SPRAYING SET FOR DELAWARE COUNTY TO CONTROL WEST NILE VIRUS THREAT
MOSQUITO SPRAYING SET FOR BUTLER COUNTY AREA TO CONTROL WEST NILE VIRUS THREAT
MOSQUITO SPRAYING SET FOR BUCKS COUNTY TO CONTROL WEST NILE VIRUS THREAT
MOSQUITO SPRAYING SET FOR COLUMBIA COUNTY TO CONTROL WEST NILE VIRUS THREAT
MOSQUITO SPRAYING IN BERKS COUNTY TO CONTROL WEST NILE VIRUS THREAT
September 4th, 2008 at 10:25 am
GenoMed, a genomics-based Disease Management company in St. Louis, has had encouraging results treating West Nile virus encephalitis since 2003.
We’ve had about 80% treatment success rate in people (23 of 29 improved) and horses (8 of 10 survived), and 50% in birds (6 of 12 survived). Our first 8 human WNV patients were published in a peer-reviewed medical journal in 2004 (1). This is sufficient for our treatment to officially exist in both the medical and legal senses.
The earlier our treatment is begun, the better the outcome.
Anybody who wants to download our WNV trial protocol can do so for free at any time by clicking on the “West Nile trial” link on our company’s homepage at http://www.genomed.com.
Dave Moskowitz MD
CEO & Chief Medical Officer
GenoMed, Inc. (Ticker symbol GMED on OTC Pink Sheets)
“The public health company™”
1. Moskowitz DW, Johnson FE. The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. Curr Top Med Chem. 2004;4(13):1433-54. PMID: 15379656 (For PDF file, click on paper #6 at: http://www.genomed.com/index.cfm?action=investor&drill=publications)